1st Nov 2016 11:15
SHIRE PLC - Director/PDMR ShareholdingSHIRE PLC - Director/PDMR Shareholding
PR Newswire
London, November 1
Director/PDMR Shareholding
November 1, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”)
Notification of transactions by persons discharging managerial responsibilities
1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
a) | Name | Ginger Gregory | |
2. | Reason for the notification | ||
a) | Position / status | Chief Human Resources Officer - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Dr. Gregory has elected to save $400.00 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2016, and 85% of the fair market value of an ADS on October 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
N/A | N/A | ||
d) | Aggregated information | N/A (single transaction) | |
e) | Date of the transaction | November 1, 2016 | |
f) | Place of the transaction | N/A |
1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
a) | Name | Bill Mordan | |
2. | Reason for the notification | ||
a) | Position / status | General Counsel and Company Secretary - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Mr. Mordan has elected to save $480.77 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2016, and 85% of the fair market value of an ADS on October 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
N/A | N/A | ||
d) | Aggregated information | N/A (single transaction) | |
e) | Date of the transaction | November 1, 2016 | |
f) | Place of the transaction | N/A |
1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
a) | Name | Flemming Ornskov | |
2. | Reason for the notification | ||
a) | Position / status | Chief Executive Officer - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Dr. Ornskov has elected to save $480.77 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2016, and 85% of the fair market value of an ADS on October 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
N/A | N/A | ||
d) | Aggregated information | N/A (single transaction) | |
e) | Date of the transaction | November 1, 2016 | |
f) | Place of the transaction | N/A |
1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
a) | Name | Jeff Poulton | |
2. | Reason for the notification | ||
a) | Position / status | Chief Financial Officer - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Mr. Poulton has elected to save $480.77 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2016, and 85% of the fair market value of an ADS on October 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
N/A | N/A | ||
d) | Aggregated information | N/A (single transaction) | |
e) | Date of the transaction | November 1, 2016 | |
f) | Place of the transaction | N/A |
1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
a) | Name | Perry Sternberg | |
2. | Reason for the notification | ||
a) | Position / status | Head of US Commercial - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Mr. Sternberg has elected to save $480.77 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2016, and 85% of the fair market value of an ADS on October 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
N/A | N/A | ||
d) | Aggregated information | N/A (single transaction) | |
e) | Date of the transaction | November 1, 2016 | |
f) | Place of the transaction | N/A |
1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
a) | Name | Kim Stratton | |
2. | Reason for the notification | ||
a) | Position / status | Head of International Commercial - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”) | |
Identification code | ISIN: JE00B2QKY057 | ||
b) | Nature of the transaction | Receipt of option over notional Ordinary Shares granted under the Shire Global Employee Stock Purchase Plan. Ms. Stratton has elected to save Fr.1,009.83 per month. The option price will be the lower of 85% of the fair market value of an Ordinary Share on October 31, 2016, and 85% of the fair market value of an Ordinary Share on October 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
N/A | N/A | ||
d) | Aggregated information | N/A (single transaction) | |
e) | Date of the transaction | November 1, 2016 | |
f) | Place of the transaction | N/A |
1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
a) | Name | Phil Vickers | |
2. | Reason for the notification | ||
a) | Position / status | Head of Research and Development - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Dr. Vickers has elected to save $480.77 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2016, and 85% of the fair market value of an ADS on October 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
N/A | N/A | ||
d) | Aggregated information | N/A (single transaction) | |
e) | Date of the transaction | November 1, 2016 | |
f) | Place of the transaction | N/A |
1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
a) | Name | Matt Walker | |
2. | Reason for the notification | ||
a) | Position / status | Head of Technical Operations - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Mr. Walker has elected to save $480.77 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2016, and 85% of the fair market value of an ADS on October 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
N/A | N/A | ||
d) | Aggregated information | N/A (single transaction) | |
e) | Date of the transaction | November 1, 2016 | |
f) | Place of the transaction | N/A |
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
Investor Relations | ||
Sarah Elton-Farr | [email protected] | +44 1256 894157 |
Ian Karp | [email protected] | +1 781 482 9018 |
Robert Coates | [email protected] | +44 1256 894874 |
Media | ||
Gwen Fisher | [email protected] | +1 484 595 9836 |
Debbi Ford | [email protected] | +1 617 949 9083 |
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.
www.shire.com
Related Shares:
Shire